The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study. 1986

P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little

The prevalence rates of xanthelasma and corneal arcus were computed for normolipidemic and dyslipoproteinemic participants in the Lipid Research Clinics population surveys. The prevalence of both xanthelasma and corneal arcus increased with age, was highest in persons with type II phenotype, and usually low in those with type IV phenotype. The relative effects of age and use of gonadal hormones were different in the two lesions. Both xanthelasma and corneal arcus were associated with increased levels of plasma cholesterol and low-density lipoprotein cholesterol (LDL-C), especially in young males. In general, persons with either lesion had increased odds of having type IIa dyslipoproteinemia but decreased odds of having type IV. Xanthelasma and corneal arcus were highly associated with each other, especially in young people. There was no consistent univariate association of xanthelasma and corneal arcus with smoking, alcohol consumption, blood pressure, obesity, sedentary lifestyle, family history of ischemic heart disease, or glucose and uric acid plasma concentrations. Adjusted odds ratios for ischemic heart disease in participants with xanthelasma and corneal arcus were generally increased, except in older female nonusers of gonadal hormones, in whom they were significantly decreased. Neither xanthelasma nor corneal arcus showed a consistent association with manifestations of peripheral arterial disease. Thus the clinical findings of xanthelasma or corneal arcus, especially in young people, seem to identify persons with plasma lipoprotein abnormalities.

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D007009 Hypolipoproteinemias Conditions with abnormally low levels of LIPOPROTEINS in the blood. This may involve any of the lipoprotein subclasses, including ALPHA-LIPOPROTEINS (high-density lipoproteins); BETA-LIPOPROTEINS (low-density lipoproteins); and PREBETA-LIPOPROTEINS (very-low-density lipoproteins). Hypolipoproteinemia,Hypoprebetalipoproteinemia
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003316 Corneal Diseases Diseases of the cornea. Corneal Disease,Disease, Corneal,Diseases, Corneal
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005141 Eyelid Diseases Diseases involving the EYELIDS. Disease, Eyelid,Diseases, Eyelid,Eyelid Disease
D005260 Female Females

Related Publications

P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little
January 1986, Circulation,
P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little
January 1986, Circulation,
P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little
January 1986, Circulation,
P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little
January 1986, Circulation,
P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little
January 1986, Circulation,
P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little
January 1986, Circulation,
P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little
November 1980, Circulation,
P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little
January 1986, Circulation,
P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little
January 2003, Medicinski arhiv,
P Segal, and W Insull, and L E Chambless, and S Stinnett, and J C LaRosa, and L Weissfeld, and S Halfon, and P O Kwiterovitch, and J A Little
January 1986, Atherosclerosis,
Copied contents to your clipboard!